Stammdaten
Veracyte, Inc. ist weltweit als Diagnostikunternehmen tätig. Das Unternehmen bietet Afirma Genomic Sequencing Classifier und Xpression Atlas zur Bestimmung, ob Patienten mit unbestimmten Befunden benigne Funde haben, um vermeidbare Operationen zu verhindern; Decipher Prostate Biopsy und Radical Prostatectomy für die Prostatakrebsdiagnose; Prosigna Breast Cancer Assay für die Brustkrebsdiagnose; Percepta Genomic Sequencing Classifier und Percepta Nasal Swab Test für die Lungenkrebsdiagnose; Envisia Genomic Classifier für die Diagnose der idiopathischen Lungenfibrose; und Immunoscore Colon Cancer Test für die Darmkrebsdiagnose. Das Unternehmen entwickelt auch Percepta Genomic Atlas zur Unterstützung von Lungenkrebsbehandlungsentscheidungen; Envisia Classifier, das nCounter-Analysesystem; und LymphMark für einen Lymphom-Subtyp-Test. Veracyte, Inc. hat Technologielizenzierungs- und Kooperationsverträge mit Johnson & Johnson, Acerta Pharma und CareDx. Das Unternehmen war früher als Calderome, Inc. bekannt und änderte seinen Namen im März 2008 in Veracyte, Inc. Veracyte, Inc. wurde 2006 gegründet und hat seinen Sitz in South San Francisco, Kalifornien. KI
Unternehmen & Branche
| Name | VERACYTE, INC. |
|---|---|
| Ticker | VCYT |
| CIK | 0001384101 |
| Börse | Nasdaq |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | 92337F107 |
|---|---|
| ISIN | US92337F1075 |
| Typ | Common Stock |
| Marktkapitalisierung | 4,69 Mrd. USD |
| KGV (P/E) | 72,11 |
| Beta | 1,90 |
Sitz & Kontakt
| Sitz (Inkorporation) | DE |
|---|---|
| Geschäftsadresse | 6000 SHORELINE COURT, SUITE 300, 94080 SOUTH SAN FRANCISCO, CA |
| Telefon | (650) 243-6300 |
| EIN (IRS) | 20-5455398 |
Listing & Historie
| Listing-Börsen | Nasdaq |
|---|---|
| Fiskaljahr-Ende | 31.12. |
| SEC-Filer-Status | Large accelerated filer |
| Frühere Namen | CALDEROME INC (bis 2008) |
Bewertung
| KBV (P/B) | 3,58 vs. 2,67 (2021) ▲ |
|---|---|
| KUV (P/S) | 9,07 vs. 13,35 (2021) ▼ |
| EV/EBITDA | 55,2 |
| FCF-Rendite | 2,7 % vs. -1,3 % (2021) ▲ |
Qualität & Bilanz
| Bruttomarge | 70,1 % |
|---|---|
| Operative Marge | 11,2 % vs. -37,3 % (2021) ▲ |
| Nettomarge | 12,8 % vs. -34,4 % (2021) ▲ |
| ROIC | 4,9 % vs. -6,8 % (2021) ▲ |
| Nettoverschuldung/EBITDA | -4,1 |
| Forderungslaufzeit (DSO) | 32 T vs. 69 T (2021) ▼ |
| Lagerreichweite (DIO) | 49 T |
| Verbindlichkeitslaufzeit (DPO) | 11 T |
| Cash-Conversion-Cycle (CCC) | 69 T |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | TTM* | Verlauf |
|---|---|---|---|---|---|---|---|
| Bewertung | |||||||
| KBV (P/B) | 2,67 | 1,59 | 1,93 | 2,62 | 2,55 | 3,49 | |
| KUV (P/S) | 13,35 | 5,76 | 5,58 | 6,91 | 6,46 | 8,66 | |
| EV/EBITDA | – | – | – | 73,0 | 38,1 | 45,1 | |
| FCF-Rendite | -1,3 % | -0,1 % | 1,7 % | 2,1 % | 3,8 % | 3,3 % | |
| Qualität & Bilanz | |||||||
| Bruttomarge | – | 59,2 % | 63,6 % | 66,9 % | 70,1 % | 70,9 % | |
| Operative Marge | -37,3 % | -13,9 % | -23,8 % | 3,6 % | 11,2 % | 14,3 % | |
| Nettomarge | -34,4 % | -12,3 % | -20,6 % | 5,4 % | 12,8 % | 16,2 % | |
| ROIC | -6,8 % | -3,4 % | -7,0 % | 2,0 % | 4,9 % | 6,4 % | |
| Nettoverschuldung/EBITDA | – | – | – | -4,8 | -4,1 | -2,3 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
TTM* = letzte zwölf Monate (vorläufig, ungeprüft): jüngstes Geschäftsjahr + laufendes YTD − Vorjahres-YTD aus den Quartalsberichten (10-Q); Bewertungs-Multiples gegen die aktuelle Marktkapitalisierung. Kein testierter Jahresabschluss.
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Glück Conviction Score™ ⓘ
ⓘ
VCYT
VERACYTE, INC.
Effektiv
Schwach
Handelsvolumen
Mittel
Insider
0,0
Keine Insider-Käufe
Institutionell
48,1
46 neu, 142 erhöht, -973508K $ netto
Aktivist
38,1
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,71% (Stand: 30.06.2026)
Score-Verlauf (90 Tage)
Konviktions-Verlauf — oben stark · Mitte neutral · unten schwach
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (24 Monate)
Indexierte Darstellung (Start = 100) — die Kursform bleibt sichtbar, absolute Kurse sind angemeldeten Mitgliedern vorbehalten.
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 50.40 | +13.6 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 40.95 | +39.8 % vs SMA200 | |
| SMA-Cross | Bullisch | 10 % | GOLDEN | vor 29 Tagen @ 48.73 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 56.57 | EMA50: 51.17 | |
| MACD-Histogramm | Bärisch | 10 % | -0.491 | Bearisch | |
| RSI(14) | Neutral | 10 % | 55.7 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 45.2 | Neutral | |
| ADX(14)+DI | Bullisch | 10 % | 34.0 | +DI: 25.6 / −DI: 13.5 | |
| Z-Score(60) | Neutral | 5 % | 1.09 | In Range | |
| 52W-Position | Bullisch | 5 % | 91.4 % | Hoch 60.49 / Tief 23.03 | |
| Bollinger(20,2σ) | Neutral | 5 % | 44.0 % | Upper 61.58 / Mid 57.72 / Lower 53.86 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.4922 | R²=0.93 / annualisiert +260.2 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-06-18 | EASTHAM KARIN | Director | Open Market Sale | -529 | 53,55 | -28.328,16 | -7,2% | |
| 2026-06-18 | EASTHAM KARIN | Director | Open Market Sale | -3.200 | 52,78 | -168.906,24 | -42,9% | |
| 2026-06-04 | McGuire Annie | Officer, EVP, General Counsel | Open Market Sale | -1.400 | 49,31 | -69.028,54 | -17,5% | |
| 2026-06-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -1.600 | 49,28 | -78.853,76 | -20,0% | |
| 2026-06-04 | McGuire Annie | Officer, EVP, General Counsel | Open Market Sale | -1.776 | 50,12 | -89.007,44 | -22,6% | |
| 2026-06-04 | Leite John | Officer, Global Chief Commercial Off | Open Market Sale | -13.975 | 50,07 | -699.732,44 | -177,8% | |
| 2026-06-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -138.051 | 50,12 | -6.919.585,49 | -1758,6% | |
| 2026-06-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -1.961 | 50,09 | -98.229,04 | -25,0% | |
| 2026-05-22 | Wygant Jonathan | Officer, VP, Chief Accounting Officer | Open Market Sale | -24.000 | 45,40 | -1.089.624,00 | -276,9% | |
| 2026-05-20 | EPSTEIN ROBERT S | Director | Open Market Sale | -10.000 | 44,01 | -440.129,00 | -111,9% | |
| 2026-05-06 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -5.102 | 40,00 | -204.080,00 | -51,9% | |
| 2026-05-06 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -5.102 | 38,05 | -194.131,10 | -49,3% | |
| 2026-03-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -1.664 | 36,34 | -60.468,60 | -15,4% | |
| 2026-03-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -13.941 | 36,33 | -506.459,80 | -128,7% | |
| 2026-03-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -4.400 | 35,55 | -156.409,44 | -39,8% | |
| 2026-03-04 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -5.260 | 35,19 | -185.082,57 | -47,0% | |
| 2026-03-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -26.279 | 36,28 | -953.367,96 | -242,3% | |
| 2026-03-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -19.244 | 35,56 | -684.226,19 | -173,9% | |
| 2026-03-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -4.994 | 35,29 | -176.256,24 | -44,8% | |
| 2026-03-02 | Febbo Phillip G. | Officer, Chief Scientific & Med Officer | Open Market Sale | -13.425 | 36,16 | -485.429,21 | -123,4% | |
| 2025-12-16 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -100 | 43,68 | -4.368,00 | -1,1% | |
| 2025-12-16 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -10.639 | 43,13 | -458.835,60 | -116,6% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -6.392 | 44,52 | -284.571,20 | -72,3% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -12.808 | 45,84 | -587.080,30 | -149,2% | |
| 2025-12-05 | EASTHAM KARIN | Director | Open Market Sale | -800 | 46,59 | -37.271,84 | -9,5% | |
| 2025-12-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -4.741 | 47,25 | -224.008,93 | -56,9% | |
| 2025-12-04 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -1.278 | 47,51 | -60.717,78 | -15,4% | |
| 2025-12-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -3.220 | 47,35 | -152.462,17 | -38,7% | |
| 2025-12-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -4.448 | 46,90 | -208.613,42 | -53,0% | |
| 2025-12-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -702 | 47,51 | -33.352,02 | -8,5% | |
| 2025-12-04 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -720 | 47,10 | -33.908,76 | -8,6% | |
| 2025-12-04 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -8.537 | 46,61 | -397.946,28 | -101,1% | |
| 2025-11-25 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -2.808 | 50,00 | -140.400,00 | -35,7% | |
| 2025-11-25 | JONES EVAN/ FA | Director | Open Market Sale | -1.106 | 50,25 | -55.575,73 | -14,1% | |
| 2025-11-20 | Holstein Jens | Director | Open Market Sale | -1.491 | 40,95 | -61.060,33 | -15,5% | |
| 2025-11-20 | Holstein Jens | Director | Open Market Sale | -1.460 | 43,21 | -63.085,87 | -16,0% | |
| 2025-11-20 | Holstein Jens | Director | Open Market Sale | -7.049 | 42,48 | -299.416,85 | -76,1% | |
| 2025-11-10 | Wygant Jonathan | Officer, VP, Chief Accounting Officer | Open Market Sale | -5.102 | 42,33 | -215.978,37 | -54,9% | |
| 2025-11-07 | Wygant Jonathan | Officer, VP, Chief Accounting Officer | Open Market Sale | -5.818 | 40,21 | -233.928,98 | -59,5% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -657 | 46,38 | -30.468,77 | -7,7% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -408 | 41,74 | -17.031,18 | -4,3% | |
| 2025-11-05 | EASTHAM KARIN | Director | Open Market Sale | -9.674 | 40,02 | -387.191,21 | -98,4% | |
| 2025-11-05 | Chambers Rebecca | Officer, Chief Financial Officer | Open Market Sale | -7.000 | 41,00 | -287.000,00 | -72,9% | |
| 2025-11-05 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -6.466 | 40,00 | -258.640,00 | -65,7% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -24.296 | 45,73 | -1.110.990,48 | -282,4% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -10.837 | 43,80 | -474.701,78 | -120,6% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -5.872 | 45,07 | -264.640,47 | -67,3% | |
| 2025-11-05 | JONES EVAN/ FA | Director | Open Market Sale | -1.126 | 43,03 | -48.455,05 | -12,3% | |
| 2025-10-06 | Febbo Phillip G. | Officer, Chief Scientific & Med Officer | Open Market Sale | -8.349 | 36,02 | -300.709,27 | -76,4% | |
| 2025-10-01 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -2.160 | 35,00 | -75.607,56 | -19,2% | |
| 2025-10-01 | EPSTEIN ROBERT S | Director | Open Market Sale | -21.473 | 35,08 | -753.204,13 | -191,4% | |
| 2025-10-01 | Leite John | Officer, Chief Commercial Officer-CLIA | Open Market Sale | -2.539 | 35,00 | -88.865,00 | -22,6% | |
| 2025-09-19 | McGuire Annie | Officer, SVP, General Counsel | Open Market Sale | -2.283 | 33,69 | -76.919,52 | -19,5% | |
| 2025-09-04 | Stapley Marc | Director, Officer, Chief Executive Officer | Open Market Sale | -7.667 | 30,41 | -233.132,77 | -59,3% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
⚠ Vorläufige Daten: Erst 1693 von typischerweise 8373 Fonds (20 %) haben für das aktuelle 13F-Quartal eingereicht — Werte können sich in den kommenden Wochen noch deutlich ändern.
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13.172.618 | 0 | 13.172.618 | 424.290.027 | Neu | +100,0% | |
| FMR LLC | 7.763.849 | 0 | 7.763.849 | 250.073.568 | Neu | +100,0% | |
| Artisan Partners Limited Partnership | 5.496.370 | 0 | 5.496.370 | 177.038.065 | Neu | +100,0% | |
| STATE STREET CORP | 5.043.590 | 0 | 5.043.590 | 162.454.034 | Neu | +100,0% | |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.532.232 | 0 | 3.532.232 | 113.773.193 | Neu | +100,0% | |
| ARK Investment Management LLC | 3.053.818 | 0 | 3.053.818 | 98.363.488 | Neu | +100,0% | |
| DIMENSIONAL FUND ADVISORS LP | 2.881.090 | 0 | 2.881.090 | 92.787.245 | Neu | +100,0% | |
| WELLINGTON MANAGEMENT GROUP LLP | 2.558.285 | 0 | 2.558.285 | 82.402.360 | Neu | +100,0% | |
| FIRST TRUST ADVISORS LP | 2.117.046 | 0 | 2.117.046 | 68.190.051 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 1.957.096 | 0 | 1.957.096 | 63.049.182 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 1.448.897 | 0 | 1.448.897 | 46.668.973 | Neu | +100,0% | |
| FULLER & THALER ASSET MANAGEMENT, INC. | 1.414.362 | 0 | 1.414.362 | 45.556.610 | Neu | +100,0% | |
| ArrowMark Colorado Holdings LLC | 1.374.103 | 0 | 1.374.103 | 44.259.858 | Neu | +100,0% | |
| GOLDMAN SACHS GROUP INC | 1.276.260 | 0 | 1.276.260 | 41.108.335 | Neu | +100,0% | |
| Sumitomo Mitsui Trust Group, Inc. | 1.055.656 | 0 | 1.055.656 | 34.002.680 | Neu | +100,0% | |
| Amova Asset Management Americas, Inc. | 1.045.047 | 0 | 1.045.047 | 33.629.612 | Neu | +100,0% | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 989.687 | 0 | 989.687 | 31.877.818 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 929.500 | 0 | 929.500 | 29.939.195 | Neu | +100,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 923.573 | 0 | 923.573 | 29.748.286 | Neu | +100,0% | |
| Legal & General Group Plc | 897.171 | 0 | 897.171 | 28.897.877 | Neu | +100,0% | |
| OBERWEIS ASSET MANAGEMENT INC/ | 839.834 | 0 | 839.834 | 27.051.053 | Neu | +100,0% | |
| Alyeska Investment Group, L.P. | 808.570 | 0 | 808.570 | 26.044.040 | Neu | +100,0% | |
| MORGAN STANLEY | 797.802 | 0 | 797.802 | 25.697.233 | Neu | +100,0% | |
| Fisher Asset Management, LLC | 736.270 | 0 | 736.270 | 23.715.255 | Neu | +100,0% | |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 726.000 | 0 | 726.000 | 23.384.460 | Neu | +100,0% | |
| BAMCO INC /NY/ | 655.522 | 0 | 655.522 | 21.114.364 | Neu | +100,0% | |
| AEGON ASSET MANAGEMENT UK PLC | 326.098 | 326.627 | -529 | 19.151.736 | Reduziert | -0,2% | |
| SEGALL BRYANT & HAMILL, LLC | 591.488 | 0 | 591.488 | 19.051.828 | Neu | +100,0% | |
| FRED ALGER MANAGEMENT, LLC | 579.460 | 0 | 579.460 | 18.664.407 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 573.096 | 0 | 573.096 | 18.459.000 | Neu | +100,0% | |
| Point72 Asset Management, L.P. | 483.904 | 0 | 483.904 | 15.586.548 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 476.686 | 0 | 476.686 | 15.354.056 | Neu | +100,0% | |
| NEW YORK STATE COMMON RETIREMENT FUND | 421.633 | 0 | 421.633 | 13.580.799 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 420.093 | 0 | 420.093 | 13.531.202 | Neu | +100,0% | |
| BNP PARIBAS FINANCIAL MARKETS | 362.836 | 0 | 362.836 | 11.686.948 | Neu | +100,0% | |
| JUPITER ASSET MANAGEMENT LTD | 355.604 | 0 | 355.604 | 11.454.005 | Neu | +100,0% | |
| RAYMOND JAMES FINANCIAL INC | 370.261 | 0 | 370.261 | 11.355.744 | Neu | +100,0% | |
| Soleus Capital Management, L.P. | 319.912 | 0 | 319.912 | 10.304.366 | Neu | +100,0% | |
| BALYASNY ASSET MANAGEMENT L.P. | 298.955 | 0 | 298.955 | 9.629.341 | Neu | +100,0% | |
| Granite Investment Partners, LLC | 298.589 | 0 | 298.589 | 9.617.552 | Neu | +100,0% | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 282.835 | 0 | 282.835 | 9.110.115 | Neu | +100,0% | |
| Champlain Investment Partners, LLC | 281.923 | 0 | 281.923 | 9.080.740 | Neu | +100,0% | |
| Casdin Capital, LLC | 276.308 | 0 | 276.308 | 8.899.881 | Neu | +100,0% | |
| Nuveen, LLC | 238.439 | 0 | 238.439 | 7.680.120 | Neu | +100,0% | |
| ARDSLEY ADVISORY PARTNERS LP | 125.000 | 125.000 | 0 | 7.341.250 | Unverändert | 0,0% | |
| Summit Creek Advisors LLC | 225.894 | 0 | 225.894 | 7.276.046 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 223.500 | 0 | 223.500 | 7.198.935 | Neu | +100,0% | |
| NORDEA INVESTMENT MANAGEMENT AB | 227.581 | 0 | 227.581 | 7.134.664 | Neu | +100,0% | |
| RHUMBLINE ADVISERS | 213.234 | 0 | 213.234 | 6.868.242 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 211.683 | 0 | 211.683 | 6.818.309 | Neu | +100,0% |
Top-Fondshalter (Stand: 30.06.2026) ⓘ
⚠ Vorläufige Daten: Erst 1693 von typischerweise 8373 Fonds (20 %) haben für dieses Quartal eingereicht. Vollständigkeit erwartet bis 14.08.2026. Auswertungen (NEW/INC/DEC) sind noch zu konservativ — viele Spätfiler erscheinen aktuell als „Exits".
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) | Stimmkontrolle | Verlauf |
|---|---|---|---|---|---|---|---|
| AEGON ASSET MANAGEMENT UK PLC | 326.098 | 326.627 | -0,2% | 19.151.736 | 53,06 | 98 % | 16 Q |
| ARDSLEY ADVISORY PARTNERS LP | 125.000 | 125.000 | 0,0% | 7.341.250 | 20,34 | 100 % | 3 Q |
| Louisiana State Employees Retirement System | 35.000 | 35.100 | -0,3% | 2.055.550 | 5,69 | 100 % | 4 Q |
| Assenagon Asset Management S.A. | 27.038 | 27.038 | 0,0% | 1.587.942 | 4,40 | 100 % | 16 Q |
| YOUSIF CAPITAL MANAGEMENT, LLC | 21.596 | 21.488 | +0,5% | 1.268.333 | 3,51 | 25 % | 4 Q |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 18.922 | 19.548 | -3,2% | 1.111.289 | 3,08 | 100 % | 4 Q |
| AMI ASSET MANAGEMENT CORP | 18.905 | 38.504 | -50,9% | 1.110.291 | 3,08 | 100 % | 14 Q |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 13.110 | 10.656 | +23,0% | 746.877 | 2,07 | 1 % | 7 Q |
| QRG CAPITAL MANAGEMENT, INC. | 11.131 | 10.975 | +1,4% | 653.724 | 1,81 | 100 % | 12 Q |
| Diversified Trust Co | 8.571 | 17.775 | -51,8% | 503.374 | 1,39 | 0 % | 17 Q |
| Sowell Financial Services LLC | 3.566 | 0 | +100,0% | 209.431 | 0,58 | 100 % | 1 Q |
| Signature Resources Capital Management, LLC | 2.034 | 2.034 | 0,0% | 119.457 | 0,33 | 0 % | 9 Q |
| GAMMA Investing LLC | 1.121 | 925 | +21,2% | 65.836 | 0,18 | 100 % | 11 Q |
| Farther Finance Advisors, LLC | 902 | 1.042 | -13,4% | 53.020 | 0,15 | 0 % | 15 Q |
| FIRST HORIZON CORP | 608 | 605 | +0,5% | 35.708 | 0,10 | 0 % | 4 Q |
| Spire Wealth Management | 300 | 0 | +100,0% | 17.619 | 0,05 | – | 1 Q |
| Versant Capital Management, Inc | 261 | 294 | -11,2% | 15.329 | 0,04 | 100 % | 11 Q |
| Sachetta, LLC | 155 | 0 | +100,0% | 9.104 | 0,03 | 0 % | 2 Q |
| SOA Wealth Advisors, LLC. | 130 | 0 | +100,0% | 7.635 | 0,02 | 100 % | 1 Q |
| IFP Advisors, Inc | 126 | 138 | -8,7% | 7.400 | 0,02 | 100 % | 17 Q |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 30.06.2026 | vorl. | 34 | 0,7 | 37 |
| 31.03.2026 | ✓ | 330 | 92,2 | 2.900 |
| 31.12.2025 | ✓ | 325 | 90,2 | 3.724 |
| 30.09.2025 | ✓ | 297 | 92,5 | 3.110 |
| 30.06.2025 | ✓ | 272 | 87,9 | 2.271 |
| 31.03.2025 | ✓ | 282 | 90,1 | 2.553 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 298.955 | 9.629.341 |
| RENAISSANCE TECHNOLOGIES LLC | 223.500 | 7.198.935 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 141.811 | 4.567.732 |
| Vestal Point Capital, LP | 130.687 | 4.209.428 |
| CONGRESS ASSET MANAGEMENT CO | 76.627 | 2.468.156 |
| Empowered Funds, LLC | 69.167 | 2.227.869 |
| Squarepoint Ops LLC | 64.154 | 2.066.400 |
| KENNEDY CAPITAL MANAGEMENT LLC | 54.320 | 1.749.647 |
| D. E. Shaw & Co., Inc. | 42.135 | 1.357.168 |
| BURNEY CO/ | 37.751 | 1.215.960 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| FMR LLC | 7.763.849 | 2.025.640 | +35.3 % | 250.073.568 |
| FIRST TRUST ADVISORS LP | 2.117.046 | 833.543 | +64.9 % | 68.190.051 |
| STATE STREET CORP | 5.043.590 | 682.677 | +15.7 % | 162.454.034 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.558.285 | 521.899 | +25.6 % | 82.402.360 |
| Soleus Capital Management, L.P. | 319.912 | 309.912 | +3099.1 % | 10.304.366 |
| GW&K Investment Management, LLC | 1.437.322 | 297.239 | +26.1 % | 46.296 |
| ROYAL BANK OF CANADA | 573.096 | 228.720 | +66.4 % | 18.459.000 |
| Alyeska Investment Group, L.P. | 808.570 | 207.014 | +34.4 % | 26.044.040 |
| Legal & General Group Plc | 897.171 | 206.414 | +29.9 % | 28.897.877 |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 989.687 | 199.262 | +25.2 % | 31.877.818 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile | Δ % | Wert (USD) |
|---|---|---|---|---|
| ARK Investment Management LLC | 3.053.818 | -833.729 | -21.4 % | 98.363.488 |
| Artisan Partners Limited Partnership | 5.496.370 | -766.671 | -12.2 % | 177.038.065 |
| Champlain Investment Partners, LLC | 281.923 | -406.859 | -59.1 % | 9.080.740 |
| MORGAN STANLEY | 797.802 | -385.267 | -32.6 % | 25.697.233 |
| Nuveen, LLC | 238.439 | -343.835 | -59.1 % | 7.680.120 |
| Amova Asset Management Americas, Inc. | 1.045.047 | -212.851 | -16.9 % | 33.629.612 |
| Sumitomo Mitsui Trust Group, Inc. | 1.055.656 | -202.242 | -16.1 % | 34.002.680 |
| ArrowMark Colorado Holdings LLC | 1.374.103 | -187.346 | -12.0 % | 44.259.858 |
| BARCLAYS PLC | 29.052 | -182.603 | -86.3 % | 935.766 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 179.700 | -177.858 | -49.7 % | 5.788.137 |
Zusätzlich aktuell von 180 Mutual Funds/ETFs gehalten (N-PORT). Alle Fondsgesellschaften & ihre 4-Quartals-Bewegungen →
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Δ-Balken |
|---|---|---|---|---|---|---|
| 05.06.2026 | Abigail P. Johnson (+1) | Passiv (13G/A) | 10,10 % | 8.059.903 | +0,40 pp | |
| 13.05.2026 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 6,90 % | 5.496.370 | -1,00 pp | |
| 12.05.2026 | STATE STREET CORPORATION | Passiv (13G) | 6,30 % | 5.043.590 | +1,00 pp | |
| 06.05.2026 | Abigail P. Johnson (+1) | Passiv (13G/A) | 9,70 % | 7.703.849 | +2,50 pp | |
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 5,20 % | 4.132.224 | Neu | |
| 29.04.2026 | Vanguard Portfolio Management | Passiv (13G) | 5,67 % | 4.512.852 | Neu | |
| 27.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -10,08 pp | |
| 05.02.2026 | Abigail P. Johnson (+1) | Passiv (13G/A) | 7,20 % | 5.688.209 | -1,40 pp | |
| 03.02.2026 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 7,90 % | 6.263.041 | -1,50 pp | |
| 08.01.2026 | ARK Investment Management LLC (+1) | Passiv (13G/A) | 4,92 % | 3.887.547 | -0,76 pp | |
| 12.11.2025 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 9,40 % | 7.370.467 | +1,30 pp | |
| 10.11.2025 | STATE STREET CORPORATION | Passiv (13G) | 5,30 % | 4.199.674 | Neu | |
| 05.11.2025 | Abigail P. Johnson (+1) | Passiv (13G/A) | 8,60 % | 6.735.697 | -1,60 pp | |
| 04.11.2025 | ARK Investment Management LLC (+1) | Passiv (13G) | 5,68 % | 4.465.775 | +1,59 pp | |
| 12.08.2025 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 8,10 % | 6.321.775 | +1,40 pp | |
| 12.08.2025 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 4,40 % | 3.473.772 | -1,11 pp | |
| 01.08.2025 | BlackRock, Inc. | Passiv (13G/A) | 15,20 % | 11.930.018 | +6,80 pp | |
| 06.06.2025 | ARK Investment Management LLC (+1) | Passiv (13G/A) | 4,09 % | 3.205.231 | -0,96 pp | |
| 15.05.2025 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 6,70 % | 5.239.711 | -1,80 pp | |
| 14.05.2025 | ARK Investment Management LLC (+1) | Passiv (13G) | 5,05 % | 3.939.302 | +0,57 pp | |
| 07.05.2025 | ARK Investment Management LLC | Passiv (13G/A) | 4,48 % | 3.491.379 | -1,93 pp | |
| 07.05.2025 | Abigail P. Johnson (+1) | Passiv (13G/A) | 10,20 % | 7.922.822 | +1,20 pp | |
| 07.05.2025 | Abigail P. Johnson (+1) | Passiv (13G) | 9,00 % | 7.020.451 | Neu | |
| 17.04.2025 | BlackRock, Inc. | Passiv (13G/A) | 8,40 % | 6.558.952 | Neu | |
| 12.02.2025 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 8,50 % | 6.599.264 | +3,30 pp | |
| 10.01.2025 | ARK Investment Management LLC | Passiv (13G/A) | 6,41 % | 4.920.745 | -5,16 pp | |
| 12.11.2024 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G) | 6,50 % | 5.022.832 | +2,10 pp | |
| 08.11.2024 | Wellington Management Company LLP | Passiv (13G/A) | 5,01 % | 3.845.237 | -4,27 pp | |
| 08.11.2024 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 5,51 % | 4.232.844 | -4,17 pp | |
| 02.10.2024 | The Vanguard Group | Passiv (13G/A) | 10,08 % | 7.748.514 | +0,33 pp | |
| 08.07.2024 | . BlackRock, Inc. | Passiv (13G/A) | 10,20 % | 7.793.059 | +0,40 pp | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 9,75 % | 7.118.211 | +0,20 pp | |
| 12.02.2024 | Artisan Partners Asset Management Inc. (+3) | Passiv (13G/A) | 4,40 % | 3.217.728 | Neu | |
| 08.02.2024 | Wellington Management Company LLP | Passiv (13G/A) | 9,28 % | 6.779.410 | -0,32 pp | |
| 08.02.2024 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 9,68 % | 7.068.435 | -0,33 pp | |
| 29.01.2024 | ARK | Passiv (13G/A) | 10,48 % | 7.655.603 | -0,62 pp | |
| 24.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 9,80 % | 7.161.866 | +0,70 pp | |
| 22.01.2024 | : STATE STREET CORPORATION | Passiv (13G/A) | 4,26 % | 0 | -1,54 pp | |
| 09.06.2023 | Wellington Investment Advisors Holdings LLP (+2) | Passiv (13G/A) | 10,01 % | 7.248.889 | +0,76 pp | |
| 09.06.2023 | Wellington Management Company LLP | Passiv (13G/A) | 9,60 % | 6.954.034 | +0,75 pp |
US Congress Trades (STOCK Act)
| Datum | Mitglied | Partei | Kammer | Typ | Betrag-Bereich |
|---|---|---|---|---|---|
| 03.03.2026 | Gilbert Cisneros | – | House | Kauf | $1,001 – $15,000 |
| 16.06.2025 | Gilbert Cisneros | – | House | Kauf | $1,001 – $15,000 |
Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →
Finanzkennzahlen (SEC XBRL) ⓘ
Währung:
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | – | 28.707.000 $ | 0,35 $ | 1.436.400.000 $ | 1.344.406.000 $ |
| 2025-12-31 | 10-K | – | 66.353.000 $ | 0,82 $ | 1.406.019.000 $ | 1.309.576.000 $ |
| 2025-09-30 | 10-Q | – | 19.137.000 $ | 0,24 $ | 1.367.787.000 $ | 1.257.667.000 $ |
| 2025-06-30 | 10-Q | – | -980.000 $ | -0,01 $ | 1.344.104.000 $ | 1.221.057.000 $ |
| 2025-03-31 | 10-Q | – | 7.047.000 $ | 0,09 $ | 1.315.411.000 $ | 1.194.936.000 $ |
| 2024-12-31 | 10-K | – | 24.138.000 $ | 0,31 $ | 1.300.035.000 $ | 1.175.966.000 $ |
| 2024-09-30 | 10-Q | – | 15.155.000 $ | 0,19 $ | 1.275.021.000 $ | 1.176.042.000 $ |
| 2024-06-30 | 10-Q | – | 5.734.000 $ | 0,07 $ | 1.234.327.000 $ | 1.132.523.000 $ |
| 2024-03-31 | 10-Q | – | -1.864.000 $ | -0,02 $ | 1.200.073.000 $ | 1.118.649.000 $ |
| 2023-12-31 | 10-K | – | -74.404.000 $ | -1,02 $ | 1.114.906.000 $ | 1.044.102.000 $ |
| 2023-09-30 | 10-Q | – | -29.618.000 $ | -0,41 $ | 1.124.943.000 $ | 1.054.059.000 $ |
| 2023-06-30 | 10-Q | – | -8.402.000 $ | -0,12 $ | 1.161.114.000 $ | 1.082.718.000 $ |
| 2023-03-31 | 10-Q | – | -8.091.000 $ | -0,11 $ | 1.157.119.000 $ | 1.081.259.000 $ |
| 2022-12-31 | 10-K | – | -36.560.000 $ | -0,51 $ | 1.156.422.000 $ | 1.075.200.000 $ |
| 2022-09-30 | 10-Q | – | -8.723.000 $ | -0,12 $ | 1.125.957.000 $ | 1.048.177.000 $ |
| 2022-06-30 | 10-Q | – | -9.532.000 $ | -0,13 $ | 1.144.198.000 $ | 1.064.151.000 $ |
| 2022-03-31 | 10-Q | – | -14.461.000 $ | -0,20 $ | 1.173.589.000 $ | 1.085.190.000 $ |
| 2021-12-31 | 10-K | – | -75.563.000 $ | -1,11 $ | 1.187.825.000 $ | 1.096.514.000 $ |
| 2021-09-30 | 10-Q | – | -14.129.000 $ | -0,20 $ | 1.186.356.000 $ | 1.107.080.000 $ |
| 2021-06-30 | 10-Q | – | -9.038.000 $ | -0,13 $ | 1.027.435.000 $ | 971.177.000 $ |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Testing | 493,2 Mio. | 419,0 Mio. | 326,5 Mio. | 250,5 Mio. | 188,2 Mio. | 92,5 % | +17,7% | |
| Product | 14,3 Mio. | 13,7 Mio. | 15,6 Mio. | 12,6 Mio. | 11,5 Mio. | 2,7 % | +5,0% | |
| Biopharmaceutical And Other | 9,7 Mio. | 13,2 Mio. | 18,9 Mio. | 33,4 Mio. | 19,9 Mio. | 1,8 % | -26,5% | |
| Biopharmaceutical And Other Biopharmaceutical Revenue | 6,5 Mio. | 7,1 Mio. | 13,9 Mio. | 26,3 Mio. | – | 1,2 % | -8,6% | |
| Testing Other | 6,2 Mio. | 11,8 Mio. | 7,8 Mio. | – | – | 1,2 % | -47,5% | |
| Biopharmaceutical And Other Contract Manufacturing And Testing | 3,1 Mio. | 6,0 Mio. | 5,0 Mio. | 7,0 Mio. | – | 0,6 % | -47,9% | |
| Biopharmaceutical And Other Development Services | – | – | – | – | 10,4 Mio. | – | – | |
| Biopharmaceutical And Other Collaboration Milestones | – | – | – | – | 4,0 Mio. | – | – | |
| Biopharmaceutical And Other Contract Manufacturing | – | – | – | – | 2,9 Mio. | – | – | |
| Biopharmaceutical And Other Provision Of Data | – | – | – | – | 1,9 Mio. | – | – | |
| Biopharmaceutical And Other Contract Testing | – | – | – | – | 383.000 | – | – | |
| Biopharmaceutical And Other Milestones Excluding Collaboration | – | – | – | – | 350.000 | – | – |
Regionen
| Region | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| US | 496,6 Mio. | 423,5 Mio. | 334,5 Mio. | 262,9 Mio. | 201,0 Mio. | 96,0 % | +17,3% | |
| Non Us | 20,5 Mio. | 22,2 Mio. | 26,5 Mio. | 33,6 Mio. | 18,5 Mio. | 4,0 % | -7,6% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 06.05.2026 | 139,1 Mio. USD | 0,35 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | 131,9 Mio. USD | 0,24 |
| Q2 2025 | 30.06.2025 | 07.08.2025 | 130,2 Mio. USD | -0,01 |
| Q1 2025 | 31.03.2025 | 08.05.2025 | 114,5 Mio. USD | 0,09 |
| Q3 2024 | 30.09.2024 | 07.11.2024 | 115,9 Mio. USD | 0,19 |
| Q2 2024 | 30.06.2024 | 07.08.2024 | 114,4 Mio. USD | 0,07 |
| Q1 2024 | 31.03.2024 | 08.05.2024 | 96,8 Mio. USD | -0,02 |
| Q3 2023 | 30.09.2023 | 08.11.2023 | 90,1 Mio. USD | -0,41 |
| Q2 2023 | 30.06.2023 | 09.08.2023 | 90,3 Mio. USD | -0,12 |
Einreichungs-Historie (10-K / 10-Q / 20-F / 6-K)
SEC-Einreichungs-Historie der letzten sechs Jahre (Datum = US-Kalendertag,
SEC/ET): Quartalsberichte (10-Q) und Jahresberichte (10-K); ausländische
Emittenten (ADR/Foreign Private Issuer) reichen stattdessen Jahresberichte
(20-F/40-F) und Zwischenmitteilungen (6-K) ein — dort liegt im SEC-Index
keine Berichtsperiode vor, Periode und Verzögerung bleiben leer. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht (US) | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 06.05.2026 | 10-Q | 31.03.2026 | 36 Tage | SEC » |
| 26.02.2026 | 10-K | 31.12.2025 | 57 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 07.08.2025 | 10-Q | 30.06.2025 | 38 Tage | SEC » |
| 08.05.2025 | 10-Q | 31.03.2025 | 38 Tage | SEC » |
| 28.02.2025 | 10-K | 31.12.2024 | 59 Tage | SEC » |
| 07.11.2024 | 10-Q | 30.09.2024 | 38 Tage | SEC » |
| 07.08.2024 | 10-Q | 30.06.2024 | 38 Tage | SEC » |
| 08.05.2024 | 10-Q | 31.03.2024 | 38 Tage | SEC » |
| 29.02.2024 | 10-K | 31.12.2023 | 60 Tage | SEC » |
| 08.11.2023 | 10-Q | 30.09.2023 | 39 Tage | SEC » |
| 09.08.2023 | 10-Q | 30.06.2023 | 40 Tage | SEC » |
| 05.05.2023 | 10-Q | 31.03.2023 | 35 Tage | SEC » |
| 01.03.2023 | 10-K | 31.12.2022 | 60 Tage | SEC » |
| 03.11.2022 | 10-Q | 30.09.2022 | 34 Tage | SEC » |
| 03.08.2022 | 10-Q | 30.06.2022 | 34 Tage | SEC » |
| 04.05.2022 | 10-Q | 31.03.2022 | 34 Tage | SEC » |
| 28.02.2022 | 10-K | 31.12.2021 | 59 Tage | SEC » |
| 09.11.2021 | 10-Q | 30.09.2021 | 40 Tage | SEC » |
| 29.07.2021 | 10-Q | 30.06.2021 | 29 Tage | SEC » |
| 10.05.2021 | 10-Q | 31.03.2021 | 40 Tage | SEC » |
| 22.02.2021 | 10-K | 31.12.2020 | 53 Tage | SEC » |
| 02.11.2020 | 10-Q | 30.09.2020 | 33 Tage | SEC » |
| 30.07.2020 | 10-Q | 30.06.2020 | 30 Tage | SEC » |
Kapitalerhöhungen & Emissions-Historie
Emissions-Historie aus den finalen SEC-Prospekten: Börsengang (424B4) und Kapitalerhöhungen (424B5, Folge-/Sekundärplatzierungen). Volumen = Brutto-Erlös (bei Börsengängen zusätzlich der Ausgabepreis). Wiederholte Kapitalerhöhungen deuten auf Verwässerung der Altaktionäre hin.
| Datum (US) | Art | Volumen | |
|---|---|---|---|
| 05.02.2021 | Kapitalerhöhung | $550,0 Mio · $74,00/Aktie | SEC » |
| 03.02.2021 | Kapitalerhöhung | $400,0 Mio | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Beträge in US-Dollar.
Proxy-/Governance-Filings
Proxy-Statements (SEC DEF-14A-Familie) der letzten sechs Jahre: reguläre HV-Einladungen zur Aktionärsversammlung, Aktivisten-Proxy-Fights (contested / Non-Management-Solicitation) und M&A-Abstimmungen.
| Datum (US) | Kategorie | HV-Termin (US) | Stichtag (US) | Form | |
|---|---|---|---|---|---|
| 22.04.2026 | HV-Einladung | — | — | DEFA14A | SEC » |
| 22.04.2026 | HV-Einladung | 10.06.2026 Jahres-HV | 15.04.2026 | DEF 14A | SEC » |
| 29.04.2025 | HV-Einladung | — | — | DEFA14A | SEC » |
| 29.04.2025 | HV-Einladung | 17.06.2025 Jahres-HV | 21.04.2025 | DEF 14A | SEC » |
| 25.04.2024 | HV-Einladung | — | — | DEFA14A | SEC » |
| 25.04.2024 | HV-Einladung | 12.06.2024 Jahres-HV | 15.04.2024 | DEF 14A | SEC » |
| 01.06.2023 | HV-Einladung | — | — | DEFA14A | SEC » |
| 27.04.2023 | HV-Einladung | — | — | DEFA14A | SEC » |
| 27.04.2023 | HV-Einladung | 08.06.2023 Jahres-HV | 10.04.2023 | DEF 14A | SEC » |
| 17.04.2023 | Vorläufig | — | — | PRE 14A | SEC » |
| 26.04.2022 | HV-Einladung | — | — | DEFA14A | SEC » |
| 26.04.2022 | HV-Einladung | 15.06.2022 Jahres-HV | 18.04.2022 | DEF 14A | SEC » |
| 23.04.2021 | HV-Einladung | — | — | DEFA14A | SEC » |
| 23.04.2021 | HV-Einladung | 07.06.2021 Jahres-HV | 15.04.2021 | DEF 14A | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). HV-Termin = Datum der Aktionärsversammlung, Stichtag (Record Date) = Nachweisstichtag für die Stimmberechtigung (aus dem Dokument extrahiert).
Übernahmen & Fusionen (M&A)
M&A-relevante SEC-Filings der letzten sechs Jahre: Übernahmeangebote (Tender Offers), Fusionen (425/S-4), Aktienrückkauf-Angebote (Self-Tender) und Going-Private-Transaktionen. Geführt nach dem einreichenden Emittenten.
| Datum (US) | Kategorie | Form | Deal-Konditionen | SEC |
|---|---|---|---|---|
| 01.06.2021 | Fusion | 425 | Ziel: HalioDx SAS | SEC » |
| 03.02.2021 | Fusion | 425 | Ziel: Decipher Biosciences, Inc. | SEC » |
| 03.02.2021 | Fusion | 425 | Ziel: Decipher Biosciences, Inc. | SEC » |
| 03.02.2021 | Fusion | 425 | Ziel: Decipher Biosciences, Inc. | SEC » |
| 03.02.2021 | Fusion | 425 | Ziel: Decipher Biosciences, Inc. | SEC » |
| 03.02.2021 | Fusion | 425 | Ziel: Decipher Biosciences, Inc. · $54,30 Cash + Aktien | SEC » |
Datum = US-Einreichungsdatum (SEC EDGAR, ET). Deal-Konditionen aus dem Dokument extrahiert (Tender: SC TO-T/-I/SC 14D9; Fusion: 425/S-4 — Gegenpartei + Umtauschverhältnis), ohne Gewähr — Original siehe SEC-Link.
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (11.06.2026)
HOCH Abgang Schlüsselpersonen (11.06.2026)
| Datum | Meldung | Tags | Schwere | Filing | Auszug |
|---|---|---|---|---|---|
| 11.06.2026 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 16.03.2026 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 04.09.2024 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 13.02.2024 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Principal Officers; Election of Directors… |
| 14.12.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.08.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 22.02.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 11.01.2022 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 16.07.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 12.07.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 08.06.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 10.05.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 15.04.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 05.04.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 22.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 03.03.2021 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 17.11.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 27.07.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 09.06.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
| 02.03.2020 | Item 5.02 — Abgang Schlüsselpersonen | – | HOCH | SEC | Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers… |
8-K-Ereignisse (KI)
🔒 Die vollständige KI-Einordnung je 8-K ist Teil des Kunden-Abos — freischalten.
| Datum | Ereignis | Sentiment | Materialität | Zusammenfassung | Filing |
|---|---|---|---|---|---|
| 11.06.2026 | HV-Abstimmung | 0,15 | 40 | Aktionäre von Veracyte genehmigten auf der Jahreshauptversammlung am 10. Juni 2026 ein Amendment zur 2023 Equity Incentive Plan, das die ver… 🔒 | SEC |
| 05.05.2026 | Quartalszahlen | 0,00 | 55 | Veracyte veröffentlichte Quartalsergebnisse für Q1 2026 (abgelaufen 31. März 2026) via Pressemitteilung am 5. Mai 2026. | SEC |
| 16.03.2026 | Personalwechsel | 0,25 | 48 | Veracyte ernennt Dr. Kevin Haas als Chief Development and Technology Officer mit Wirkung zum 24. März 2026. Haas kommt vom Konkurrenten Myri… 🔒 | SEC |
| 25.02.2026 | Quartalszahlen | 0,00 | 65 | Veracyte gab am 25. Februar 2026 die Finanzergebnisse für Q4 und Geschäftsjahr 2025 ab. | SEC |
| 12.01.2026 | Quartalszahlen | 0,00 | 50 | Veracyte kündigte vorläufige, nicht geprüfte Finanzergebnisse für Q4 und das Gesamtjahr 2025 an. | SEC |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-06-30 | 181.829 | 60,19 | 10.944.288 |
| 2026-06-29 | 30 | 60,49 | 1.815 |
| 2026-06-15 | 2.435 | 47,33 | 115.249 |
| 2026-05-28 | 6.355 | 44,49 | 282.734 |
| 2026-05-26 | 9.257 | 45,03 | 416.843 |
| 2026-05-19 | 204 | 41,50 | 8.466 |
| 2026-05-15 | 59.772 | 38,90 | 2.325.131 |
| 2026-05-14 | 13 | 38,25 | 497 |
| 2026-05-08 | 116.620 | 40,76 | 4.753.431 |
| 2026-05-01 | 5.139 | 32,92 | 169.176 |
| 2026-04-30 | 18 | 31,78 | 572 |
| 2026-04-22 | 556 | 33,51 | 18.632 |
| 2026-04-21 | 3.005 | 33,45 | 100.517 |
| 2026-04-17 | 307 | 33,03 | 10.140 |
| 2026-04-10 | 1.440 | 31,35 | 45.144 |
| 2026-03-26 | 9.527 | 32,79 | 312.390 |
| 2026-03-23 | 2.159 | 31,84 | 68.743 |
| 2026-03-20 | 237 | 32,78 | 7.769 |
| 2026-03-19 | 10 | 33,28 | 333 |
| 2026-03-18 | 9.729 | 33,48 | 325.727 |
| 2026-03-13 | 23 | 30,93 | 711 |
| 2026-03-06 | 4.154 | 34,68 | 144.061 |
| 2026-03-03 | 8.368 | 36,01 | 301.332 |
| 2026-02-27 | 1.449 | 38,75 | 56.149 |
| 2026-02-06 | 527 | 34,86 | 18.371 |
| 2026-02-04 | 1.092 | 37,74 | 41.212 |
| 2026-01-23 | 2.830 | 43,80 | 123.954 |